Xcerra Corp. (XCRA) 10.31 $XCRA Xcerra (XCRA) Is Strong

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xcerra Corp. (XCRA) 10.31 $XCRA

Xcerra (XCRA) Is Strong On High Volume Today
at The Street - Thu Apr 23, 9:05AM CDT
Trade-Ideas LLC identified Xcerra (XCRA) as a strong on high relative volume candidate
XCRA: 10.31 (-0.12)

Why the Earnings Streak Will Continue for Xcerra Corporation (XCRA) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 7:55AM CDT
Xcerra Corporation has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports.
XCRA: 10.31 (-0.12)

Xcerra Announces New Instruments for Diamondx
GlobeNewswire - Mon Mar 16, 8:00AM CDT
Xcerra Corporation (Nasdaq:XCRA), today announced the first two in a series of new instruments to be introduced this year for its Diamondx test platform, a key product of its LTX-Credence brand. These new instruments will extend the capabilities of Diamondx to meet the semiconductor test challenges in fast growing markets such as mobile power management, automotive, and the Internet of Things (IoT).
XCRA: 10.31 (-0.12)

Xcerra Announces the 100th Diamondx Shipment
GlobeNewswire - Tue Mar 10, 8:00AM CDT
Xcerra Corporation (Nasdaq:XCRA), today announced a major milestone for a key product of its LTX-Credence brand, the Diamondx. The Company has shipped the 100th Diamondx test system to an OSAT in China for high volume production of HiSilicon application specific devices. This is an important milestone in the success story of the product and validation of its ability to deliver cost-optimized semiconductor test solutions to the market. While the majority of systems are deployed at OSATs (outsource semiconductor assembly and test companies), it is also well-established at fabless companies and IDMs (integrated device manufacturers).
XCRA: 10.31 (-0.12)

Can the Uptrend Continue for Xcerra (XCRA)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 6:15AM CST
Can the Uptrend Continue for Xcerra (XCRA)?
XCRA: 10.31 (-0.12)

Xcerra's (XCRA) CEO David Tacelli on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 3:39PM CST

XCRA: 10.31 (-0.12)

Xcerra beats 2Q profit forecasts
Automated Insights - Thu Feb 26, 6:12AM CST
NORWOOD, Mass. (AP) _ Xcerra Corp. (XCRA) on Thursday reported fiscal second-quarter net income of $3.9 million, after reporting a loss in the same period a year earlier.
XCRA: 10.31 (-0.12)

Xcerra beats by $0.11, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 5:58AM CST

XCRA: 10.31 (-0.12)

Xcerra Announces Second Quarter Earnings Release Date and Conference Call
GlobeNewswire - Thu Feb 19, 8:00AM CST
Xcerra Corporation (Nasdaq:XCRA), today announced the Company will release financial results for its second fiscal quarter, ended January 31, 2015, on Thursday, February 26, 2015 before the market opens. A conference call will follow at 10:00 a.m. EST to discuss the Company's second quarter fiscal 2015 financial results and third quarter fiscal 2015 guidance.
XCRA: 10.31 (-0.12)

Xcerra Announces the Acquisition of Titan Semiconductor Tool
GlobeNewswire - Thu Feb 05, 7:00AM CST
Xcerra Corporation (Nasdaq:XCRA), today announced the acquisition of substantially all of the assets and certain liabilities of Titan Semiconductor Tool, LLC ("Titan" , effective as of February 2, 2015. Titan develops, manufactures and sells innovative products for semiconductor test serving the automotive, RF/Wireless, and mixed signal test markets. Titan's patented technology includes a product line of contactors that minimize the distance between the device-under-test and the test interface board. The result is an almost transparent electrical interconnect. The acquired products will be developed, supported, and marketed by Xcerra's Multitest interface products group. Titan's technology will complement the Company's existing suite of interface product offerings. Terms of the acquisition have not been disclosed.
XCRA: 10.31 (-0.12)

Xcerra Announces Webcast of Upcoming 2015 Stifel Technology, Internet & Media Conference Presentation
GlobeNewswire - Tue Feb 03, 1:00PM CST
Xcerra Corporation (Nasdaq:XCRA) today announced that it will present at the 2015 Stifel Technology, Internet & Media Conference in California, on Tuesday, February 10, 2015 at 3:00 p.m. PST. This event will be available over the Internet via a live webcast. The webcast may be accessed via Xcerra's Investor Relations home page at http://www.xcerra.com/investors.html. A replay of the webcast will be available for 90 days following the conference.
XCRA: 10.31 (-0.12)

Chip equipment firms take Intel/TSMC's capex budgets in stride
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 6:17PM CST

ATE: 12.99 (+0.10), TSM: 24.91 (+0.61), ACLS: 2.62 (-0.03), MTSN: 3.49 (-0.26), XCRA: 10.31 (-0.12), UTEK: 19.34 (-0.13), ASML: 107.16 (-1.53), KLIC: 15.49 (-0.19), LRCX: 76.70 (-0.38), AMAT: 21.80 (-0.37), RTEC: 12.38 (-0.07), KLAC: 58.89 (-0.96), TER: 18.39 (-0.34)

Xcerra Announces Webcast of Upcoming 17th Annual Needham Growth Conference
GlobeNewswire - Tue Jan 06, 8:38AM CST
Xcerra Corporation (Nasdaq:XCRA), today announced that it will present at the 17 Annual Needham Growth Conference in New York on Tuesday, January 13, 2015 at 9:20 a.m. EST. This event will be available over the Internet via live webcast.
XCRA: 10.31 (-0.12)

Where the Companies are Headed: Complementary Research on WaferGen, Xcerra, AAR Corp., Accuride and Advanced Drainage Systems
PR Newswire - Mon Dec 29, 7:00AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including WaferGen (NASDAQ: WGBS), Xcerra (NASDAQ: XCRA), AAR Corp. (NYSE: AIR), Accuride (NYSE: ACW), and Advanced Drainage Systems (NYSE: WMS). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ACW: 4.77 (+0.10), WMS: 28.85 (+0.07), WGBS: 4.62 (+0.05), AIR: 30.14 (-0.72), XCRA: 10.31 (-0.12)

Xcerra (XCRA) Upgraded From Hold to Buy
at The Street - Mon Dec 22, 11:20AM CST
Xcerra (XCRA) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. 
XCRA: 10.31 (-0.12)

Xcerra beats Street 1Q forecasts
Automated Insights - Tue Nov 25, 6:13AM CST
NORWOOD, Mass. (AP) _ Xcerra Corp. (XCRA) on Tuesday reported fiscal first-quarter earnings of $12.1 million.
XCRA: 10.31 (-0.12)

Xcerra beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 6:05AM CST

XCRA: 10.31 (-0.12)

Xcerra Announces First Quarter Results
GlobeNewswire - Tue Nov 25, 5:55AM CST
First Fiscal Quarter Notables:
XCRA: 10.31 (-0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading